ATR and cancer: AZD6738, an orally available inhibitor of both ATR and Chk1 [344], showed synthetic lethality in various cancer cell lines [345,346], including in combination with the WEE1 inhibitor AZD1775, causing mitotic catastrophe in triple-negative breast cancer cell lines [347].